Aspergillus and Candida in primary and secondary immunodeficiencies in USIDNET

The human body maintains a delicate truce with the microscopic world. Most of the time, the fungi that live on our skin and in the air around us are harmless neighbors, kept in check by a sophisticated immune system that acts like a vigilant security force. When that security force is weakened, however, these ordinary organisms can turn into dangerous invaders. Some people are born with genetic conditions that leave specific gaps in their defenses, while others acquire weaknesses later in life through medical treatments or transplants. In these vulnerable states, two types of fungi, Aspergillus and Candida, often become the first sign that something is wrong. Aspergillus is a mold found everywhere in the environment, and breathing in its spores can lead to severe lung infections in those who cannot fight it off. Candida is a yeast that normally lives on the body but can cause serious illness if it spreads from the skin or mouth into the blood or internal organs. For decades, doctors have used these infections as clues to diagnose the underlying immune problems, but the exact map of which immune failures lead to which fungal infections has remained somewhat unclear.

A team of researchers set out to draw a clearer picture of this relationship by looking at a large collection of patient records from across the United States. They turned to the USIDNET registry, a database that tracks individuals with primary immunodeficiencies, or inborn errors of immunity, as well as those with secondary weaknesses caused by medical treatments. The researchers focused specifically on patients who had been diagnosed with deep, serious infections of either Aspergillus or Candida. They were careful to exclude minor skin rashes, looking only at severe cases like infections in the lungs, blood, or brain. By examining the medical histories of these patients, the team wanted to see if these fungal infections were linked only to the specific immune defects previously thought to cause them, or if they appeared in a much wider variety of conditions than expected.

The study identified 41 patients who had a diagnosis of Aspergillus infection. While it is well known that people with defects in their white blood cells, specifically neutrophils, are at high risk for this mold, the researchers found a much broader range of causes. Thirteen of these patients had defects affecting both their cellular and antibody-based defenses, including conditions like severe combined immunodeficiency. Twelve others had issues primarily with their antibody production, such as common variable immunodeficiency. Fourteen patients had defects in their phagocytes, the cells that eat and destroy bacteria and fungi, with the majority of these cases involving chronic granulomatous disease. The data also showed that many of these patients had undergone bone marrow transplants or were taking strong medications to suppress their immune systems, which likely increased their risk. Ten of the patients in this group had passed away, with causes of death linked to their underlying conditions or the severity of their infections.

The picture was similarly complex for the 64 patients identified with serious Candida infections. While these infections are often associated with problems in the T-cells, the researchers found them in patients with a wide array of immune system failures. Fifteen patients had combined defects in both cellular and antibody immunity, while thirteen had specific syndromes that included immune problems alongside other developmental issues. Sixteen patients had disorders primarily affecting antibody production. Interestingly, three patients with chronic granulomatous disease, a condition typically linked to Aspergillus, also suffered from severe Candida infections that had spread to their blood. The study also noted that some patients with genetic mutations affecting a specific signaling protein called STAT1 developed Candida infections in the esophagus, a pattern that aligns with the known role of this protein in controlling fungal growth on mucosal surfaces.

The researchers concluded that while these fungal infections are indeed warning signs for immune system failures, they are not exclusive to just one or two specific types of defects. Instead, Aspergillus and Candida can appear in a surprisingly diverse group of patients, including those with antibody disorders, combined defects, and various genetic syndromes. This suggests that when a patient presents with a serious fungal infection, doctors should consider a much wider range of potential underlying causes than previously assumed. The findings indicate that diagnostic testing needs to be broader to catch the full spectrum of immune deficiencies that might be hiding behind these infections. The study also highlighted the difficulty in distinguishing between immune problems a person is born with and those caused by medical treatments, as many patients in the registry had both. Ultimately, the work provides a more complete view of the landscape of immune vulnerability, showing that the body's defenses against fungi can fail in many different ways.